Impact of Right Atrial Occlusion on TEVAR Outcomes

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Calgary

About this trial

Though the application of thoracic endovascular aortic repair (TEVAR) for treatment of aortic pathology is expanding, there remains a gap in the literature examining how intraoperative "reduction or elimination of aortic impulse" (REAI) techniques, in particular the use of right atrial occlusion, may impact patient important clinical outcomes. This study aims to provide prospective data from a large cohort of TEVAR patients to explore clinical outcomes following TEVAR procedures and, specifically, whether right atrial occlusion has significant impact on clinical outcomes, as compared to other REAI techniques. The results from this study may inform future perioperative TEVAR practices and improve TEVAR patient outcomes.

Eligibility criteria

Qualifiers

age 18 years or older

thoracic endovascular aortic repair

right atrial balloon occlusion for reduction or elimination of aortic impulse

endograft deployment in landing zones 0-3

Disqualifiers

age 18 years or younger

non-thoracic endovascular aortic repair

reduction or elimination of aortic impulse using technique other than right atrial balloon occlusion

endograft deployment in landing zones 4 and beyond

Trial design

Treatments tested in this trial

  • Right atrial balloon occlusion
  • Non right atrial balloon occlusion

Treatment groups

100 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators